Q2 FY2026 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: Sangrix(SGRX) the EBIT is -4.368 M (-358.2%);the EPS is -33.33 (+35.13%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B358.19%
----
----
EPS
-33.325535.13%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf